Theme: Essential and progressive methods to treat cancer

Cancer Research 2020

Cancer Research 2020

About Conference :

The 32nd International Conference is scheduled for February 19-20, 2020 in Osaka, Japan. Cancer Research 2020 invites all the participants from all over the world which includes prompt Keynote talks, Oral talks, Poster presentations, Sponsor Ships and Exhibitions.

The aim of this conference is “Innovations and Novel Approaches in Diagnosis and Treatment of different Cancers”.

Cancer Research 2020 is comprised of many interactive scientific sessions as well as various diagnostic and therapeutic advancements in cancer. It is an initiative to unite the diverse research and business communities working in this field under a one roof to explore every single aspect of oncology.

Importance & Scope

Cancer Research 2020 will be the best platform for all the oncologists, haematologists, research scholars, students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability and quality of life.

According to market study, annual global growth in the oncology drug market is expected to be 7.5–10.5 percent through 2021, reaching $150 billion. Wider utilization of new products - especially immunotherapies - will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes. Payers also are expected to tighten their negotiation stance with manufacturers and adopt new payment models in an effort to drive greater value from their expenditures on these drugs.

The . Cancer Research 2020 is the premier event that brings together International experts, Training Institutes, Manufacturing Medical Devices Companies, Business Entrepreneurs, Medical Colleges, Researchers, Academicians, Physicians, Post Docs, Students, Pharmacy Industries, Academic scientists, Industry professionals, Diagnostic laboratory professionals and decision makers across the globe to exchange their knowledge, experience and research innovations to build Cancer Research scientists to reduce the global burden of cancer.

Cancer Research 2020 is an extraordinary event designed for International medical health professionals and oncologists to facilitate the dissemination and application of new research findings related to Cancer. The conference invites participants from all leading universities, clinical research institutions and diagnostic companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the latest techniques.

Target Audience:

Cancer Research 2020 welcomes the Oncologists, Professors, Director’s, Nurses, Research scholars, Student delegates and Industrial professionals from Biomedical and healthcare sectors can be a Target Audience.

Why you should attend Cancer Research 2020??

International conferences are great opportunities not only for researchers and scientists, but also for experts, policy makers, stakeholders and students. Here are six reasons for you to attend International conferences in your field. There is an abundance of academic conferences today as compared to the past. This brings us to a simple question, “Why should one attend an academic conference?” Below are reasons why people say they attend our conferences.

At a conference, innovative ideas are thrown about and new information is exchanged among experts. Its purpose could be one of the following: An academic conference is a gathering of scientists or academicians, where research findings are presented or a workshop is conducted.

Attending a seminar has numerous benefits, including improving communication skills, gaining expert knowledge, networking with others and renewing motivation and confidence.

Learning: Attending conferences, especially the international ones, gives you the chance to listen to different points of view and learn new ideas and trends in your field. They also provide you with new techniques, new types of equipment, data that is yet to be published, and investigators that you may not have heard of. Conferences are priceless chances to sharpen your saw by learning new skills in a different environment.

Discussion: Attending conferences allows you to learn new information and tactics from hearing others’ presentations, you also can converse with other researchers from different universities and even countries you may have only heard or read about.

Presentation: Presenting your research in a conference helps you in different ways. It presents your work to the scientific circles and helps to improve your work by getting feedback from the experts and influencers in your field. Presenting a paper is one of the main objectives of an academic conference participant. The presenter will have the chance to present a paper in front of colleagues of the same or similar fields of study and will be able to receive positive feedback and constructive criticism about their research. The exchange of ideas on fields of interests seeds the links for future collaborations across the world. There are many who were once GAI conference participants now developing research projects and writing papers together.

Visiting a new place: Attending conferences allows you to discover a new place or city where the conference is being held and learn about its people and culture. Many conferences support their attendees with a list of great places they can visit in the conference’ city or country. You can also extend your participation in the conference to a well-deserved holiday in that country and have memorable days.

Networking for future collaborations: International Conferences are great opportunities to connect with attendees from different perspectives and views, learn from them, make new relationships, and strengthen existing ones. Conferences pave the way for scientific cooperation by meeting and connecting with researchers from different countries. They also help in cooperating collective research projects such as edited books, special issues in peer-reviewed journals or funding applications. In addition, Conferences allow Experts, Stakeholders and Policymakers to communicate with researchers with innovative approaches and benefit from these relations in their businesses. Attending an academic conference is an opportunity to build networks with other academics and experts in the same or similar field of studies all around the world and to share thoughts on recent advances and technological breakthroughs. It is an opportunity to expand the knowledge that one has and upgrade performance in accomplishing institutional objectives. Conferences bring together people who share a common discipline from different parts of the world, bringing different forms of ideas which build into something greater. As you step up and attend conferences you build a network of people who can raise your caliber of work to greater heights as you achieve shared objectives.

Academic Reputation: Attending important international conferences will make you a known figure in academic circles, not to mention the benefits for your resume as it will create an impression that you are an active member of the academic community.

Travelling: An academic conference is a great way to have a “break” from your academic responsibilities at the university and discover different cities of the world. Be assured that you’ll feel relaxed and refreshed when you return to your institution after the conference.

Added Research Value: For students and researchers, academic conferences help to make research on a particular subject easier. They provide access to various research activities related to a particular subject with current findings and developments anticipated from them.

Publication: Another common reason for attending a conference is no doubt publication. Conference proceedings are always a good way to have your research published and indexed. You’ll also have the opportunity to publish your research in one of the journals.

Socialization and the culture factor: Meeting new people with different cultures and dispositions enlightens your way of thinking in your field of study. You will witness some of the many different aspects and solutions which exist on the same issues. You’ll also have the chance to socialize with your colleagues at coffee breaks, lunches and social activities. Imagine a conference without socializing or learning more about other people’s cultural tradition? This cannot be summed up adequately as people from different parts of the world who have uniqueness in their ways of living which you are often surprised to learn from.

Find out what’s new: It is vital to find out what’s new in your field of study to survive in an academic discipline. Academic conferences will keep you updated on new findings that have taken place. This is in fact one of the major reasons why one should attend an academic conference.

The focus and energy of Like-Minded Individuals: When one attends an academic conference he or she is sure to meet people of his or her same stature, mindset and goals. This is a motivational factor as one aspires to overcome fears and achieve one’s dreams.

Conclusion:

In today’s fast changing world, attending a conference has become a “must” to survive in an academic discipline. Many academics have become aware of this fact as the number of conferences and participants increase dramatically. We look forward to collaborating with you at Cancer Research 2020.

Enlightening public with recent advances in Cancer diagnosis and therapy from around the world focused on cancer about recent advances in Cancer diagnosis and therapy, this is your single best opportunity to reach the largest assemblage of participants. World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are hallmarks of this conference. Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Oncology and Cancer.

Who Should Attend Cancer Research 2020 ??

Oncologists, Radiologists, Chemotherapists, Physicians, Academicians, Industry professionals, Diagnostic laboratory professionals, Academic scientists, Postgraduate students, Postdoctoral fellows, and Trainees can attend

All individuals engaged in cancer care operations should attend the “32^nd International Conference ”, including:

Hospital presidents/CEOs/COOs/VPs/trustees
Hospital c-suite executives (operations, development, finance)
Medical directors
Oncology specialists (medical, radiation, and surgical)
Oncology program and practice administrators, managers, and service line executives
Healthcare consultants, vendors, and suppliers
Pharmaceutical and biotechnology manufacturers
Cancer program marketing and public relations professionals

How to find a virtuous conference??

Before you sign up, think about what you hope to gain from attending. Look for a conference that matches your goals for fellowship, medical knowledge, and/or new skills. And you may be surprised at how many opportunities arise.

Conference Series, which organizes 3000+ Global events, 1200+ Symposiums and 1200+Workshops every year is delighted to welcome all the enthusiastic participants across the world to its prestigious Conference on ‘32nd International Conference’ which is going to be held during February 17-18, 2020 in Osaka, Japan.

Cancer Research 2020 provides an excellent opportunity to share views, exchange knowledge and establish research collaborations & networking.

Scientific Sessions

Conference Series LLC LTD invites all the participants across the globe to attend the “32nd International Conference on Cancer Research and Therapy ” scheduled during February 19-20, 2020 at Osaka, Japan.

As the theme of the conference emphasises ‘Essential and progressive methods to treat cancer’, the Conference is an outstanding international forum to present and discuss progress in exploration, expansion, ideals, and applications of the topics related to the Cancer & Oncology.

In addition to the multidisciplinary talks, Keynote sessions, and lectures relevant to cancer & oncology research, Cancer Research 2020 is a complete 2-day event with panel discussions.

Cancer Research 2020 has been designed with many interesting and informative scientific sessions; it includes all possible aspects of oncology research.

The conference is CME & CPD Accredited.

Scientific Sessions:

Track 1: Cancer Cell Biology & Genetics

Cancer is caused when cells within the body accumulate genetic mutations and start to grow in an uncontrolled manner. Understanding how cancer develops and progresses, including how gene mutations drive the growth and spread of cancer cells, and how tumours interact with their surrounding environment, is vital for the discovery of new targeted cancer treatments.

Related Conferences:

Tumor Biology
Cancer Epigenetics
Oncogenes & Proto-oncogenes
Tumour Suppressor Genes

Track 2: Cancer & Stem Cell Therapy

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Stem Cells and Tumours cancer cells also have the characteristic which is also associated with normal stems cells. Stem Cell Therapy is using to prevent the disease. Stems cells transplant is used to treatment of cancer like leukaemia, multiple myeloma & lymphoma. Cord Blood Stem and Cancer cord blood contains haematopoietic (blood) stem cell. They have long been used in stem cell treatments for leukaemia, blood and bone marrow disorders when chemotherapy is used.

Cancer Stem Cells
Stem Cell Transplantation
Bone Marrow Transplantation
CSCs and Cancer Treatment

Track 3: Organ-Defined Cancers

Cancer can occur anywhere in the body. The most common sites of cancer among men include lung, prostate, colon, rectum, stomach and liver. And those for among women are breast, colon, rectum, lung, cervix and stomach. Cancers are often described by the body part that they originated in. However, some body parts contain multiple types of tissue, so for greater precision, cancers can additionally be classified by the type of cell that the tumour cells originated from. The type of cancer a person has needed to be known properly as different types of cancer can behave very differently and respond to different treatments.

Below are the major types of Cancer:

Breast Cancer
Gastrointestinal Cancer
Gynaecologic Cancers -Cervical Cancer
Uterus Cancer
Ovarian Cancer

Below are the major types of Cancer:

Track 4: Cancer Biomarkers

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumour or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. While some cancer biomarkers can be used to predict how aggressively your cancer will grow, and are therefore useful for assessing your prognosis, the most promising use of biomarkers today is to identify which therapies a patient’s Risk assessment, Diagnosis

Biomarkers in Cancer Medicine
Biomarkers in Medicine
Biomarkers in Cancer Research
Companion Biomarker

Track 5: Cancer Vaccines

Cancer Vaccines generally either treats existing cancer or prevents development of a cancer. Cancer treatment vaccines are made up of cancer cells, parts of cells, or pure antigens. Sometimes a patient’s own immune cells are removed and exposed to these substances in the lab to create the vaccines.

Adoptive T-Cell transfer
Therapeutic Cancer Vaccines
HPV & Hepatitis B vaccine
Personalised Cancer Vaccines
Oncoviruses

Track 6: Cancer Nanotechnology

The traditional use of nanotechnology in cancer therapeutics has been to improve the pharmacokinetics and reduce the systemic toxicities of chemotherapies through the selective targeting and delivery of these anticancer drugs to tumour tissues.

Oncoviruses
New Nano materials
Cancer Microenvironment
Early Diagnosis and Imaging
Chemo Drugs

Track 7: Cancer Pharmacology

Cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches. It also focuses on developing experimental approaches to the clinical treatment of cancer through research that bridges the fields of molecular carcinogenesis, biochemical pharmacology, radiation biology, and clinical pharmacology. It generally involves the pharmacological and oncological aspects of drugs at both

Clinical Toxicology
Pharmacokinetic
Pharmacodynamics
Drug interactions
Cancer Drug Targets

Track 8: Cancer Chemotherapy

Chemotherapy is a type of cancer treatment that uses one or more anti-cancer drugs as part of a standardized chemotherapy regimen. Chemotherapy may be given with a curative intent, or it may aim to prolong life or to reduce symptoms.

Treatment strategies
Adverse effects
Limitations
Cancer Therapeutics, Novel and experimental approaches

Track 9: Oncology: Sub-Specialities

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Different cancers affecting different parts of the body e.g. breast, prostate, lungs, blood cells (leukaemia) or other organs behave in different manner, are of different grades and cellular type, respond differently to treatment and have different set of effective treatment regimen. An oncologist is a doctor who treats cancer. Within oncology there are several sub-specialities that deal with different types of cancer.

Medical Oncology
Uro-Oncology
Neuro-oncology
Clinical Oncology
Hematologic Oncology

Track 10: Precision Cancer Medicine & Oncology

Precision medicine is the tailoring of medical treatment to the individual characteristics of each patient and his or her disease. Moreover, through the precision medicine approach, the treatment of each patient can be focused on drugs most likely to benefit him or her, sparing the patient the cost and potential harmful side effects from drugs that are unlikely to be beneficial. Oncology has been leading precision medicine efforts largely because of our immense knowledge of the role of genetic mutations in the development and progression of cancer. Precision medicine enables to approach detection, diagnosis and treatment in an in-depth way to determine how a cancer develops, grows and spreads.

Physiology & Cancer History
Identifying Risk Factors
Cancer Genomics & Biologic Factors
Targeted Agents & Conventional Treatment
New Genotyping Technologies

Track 11: Cancer Epidemiology

Cancer Epidemiology includes the study of the factors affecting cancer, to infer possible trends and causes. The study of cancer epidemiology uses epidemiological methods to find the cause of cancer and to identify and develop improved treatments. It can be used to identify events that increase or decrease cancer incidence in specific populations. The studies related to population-based research on cancer etiology, prevention, surveillance and survivorship, analytical, and molecular epidemiology, survivorship studies, risk factors, as well as the role of behavioural factors in cancer etiology and prevention are also included.

Cancer Etiology
Health Disparities
Genetic and molecular epidemiology
Environmental Carcinogens
Gene-Environment Interactions

Track 12: Cancer Therapy & Treatments

Cancer can be treated by different processes. The choice of therapy depends upon the location and grade of the tumour and the stage of the disease, as well as the general state of the patient). Many experimental cancer treatments are also under development. Some people with cancer will have only one treatment. But most people have a combination of treatments, such as surgery with chemotherapy and/or radiation therapy. You may also have immunotherapy, targeted therapy, or hormone therapy.

Radiation Therapy
Immunotherapy
Stem Cell Therapy
Cancer Surgery
Precision Medicine

Track 13: Cancer Immunology & Immunotherapy

Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells (also called tumours or malignancies). It is a field of research that aims to discover cancer immunotherapies to treat and retard progression of the disease. Cancer immunotherapy also known as Immune-oncology is the use of the immune system to treat cancer. Immunotherapies can be categorized as active, passive or hybrid (active and passive). The immune response, including the recognition of cancer-specific antigens, forms the basis of targeted therapy (such as vaccines and antibody therapies) and tumour marker-based diagnostic tests.

Clinical Cancer immunology
Cancer Antigens & Vaccines
Cellular Immunotherapy
Antibody Therapy

Track 14: Oncology Nursing and Care

Oncology Nursing is a field involving practice encompasses the roles of direct caregiver, educator, consultant, administrator, and researcher. Oncology and cancer nursing extends to all care delivery settings where clients experiencing or at risk for developing cancer receive health care, education, and counselling for cancer prevention, screening and detection. It also involves appropriate screenings and other preventative practices, symptom management, care to retain as much normal functioning as possible, and supportive measures upon end of life.

Management & Palliative Care
Treatment Plans
Supportive Care
Direct Patient Care

Track 15: Complementary & Alternative Methods and Cancer

Alternative cancer treatments may not play a direct role in curing your cancer, but they may help you cope with signs and symptoms caused by cancer and cancer treatments. CAM is the term for medical products and practices that are not part of standard care. Integrating the best of evidence-based complementary and alternative cancer treatments with the treatments you receive from your doctor may help relieve many of the symptoms associated with cancer and its treatment.

Ayurveda
Reflexology
Art & Music Therapy
Homeopathic Medicines

Track 16: Cancer Prevention & Research

Cancer prevention is defined as active measures to decrease the risk of cancer. Most of cancer cases are due to environmental risk factors, and many, but not all, of these environmental factors are controllable lifestyle choices. An individual's risk of developing cancer can be substantially reduced by healthy behaviour. Cancer Prevention Research comprises preclinical, clinical and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences.

Changing Lifestyle Choices
Preclinical & Clinical Research
Early Detection Research
Immunoprevention

Track 17: Cancer: Lifestyle Connection and Nutrition

Many factors influence the development of cancer. Over the last 25 years, science has shown that diet, physical activity, and body weight—especially being overweight or obese—are major risk factors for developing certain types of cancer. Around a third of the most common cancers could be prevented through lifestyle changes. The main behavioural and environmental risk factors for cancer mortality in the world are related to diet and physical inactivity, use of addictive substances, sexual and reproductive health and exposure to air pollution and use of contaminated needles. The body’s ability to resist cancer may be helped by following a healthy diet, staying physically active, and avoiding excess body fat. Cancer and cancer treatments can also affect your body's ability to tolerate certain foods and use nutrients.

Nutrition and Supplements
Diet and exercise
Cancer and Environment

Track 18: Tumour Virology, Immunology & Cellular Pathology

Tumor virology deals with the specific virus infections and cancer, oncogenes, tumour suppressors, oncogenic cofactors, disruption of innate/ adaptive immune responses, latency, viral mimicry/piracy of cellular regulatory genes, genomic instability and role of non-coding RNAs in viral pathogenesis. The purpose of this study is to develop viral vectors for human cancer gene therapy and to progress vaccine strategies for treatment of viral-associated cancers. Several methods are being trailed including genetic immunization with recombinant viral vectors based on Semliki Forest virus, immune checkpoint inhibitors and strategies to re-modulate the immunosuppressive tumour environment.

Cancer immunology is an interdisciplinary branch of biology that is concerned with understanding the role of the immune system in the progression and development of cancer; the most well known application is cancer immunotherapy, which utilises the immune system as a treatment for cancer.

Cytopathology is a branch of pathology that studies and diagnoses diseases on the cellular level. The discipline was founded by George Nicolas Papanicolaou in 1928. Cytopathology is generally used on samples of free cells or tissue fragments, in contrast to histopathology, which studies whole tissues.

Market Analysis :

Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. If the spread is not controlled it can result in death. Although the reason for many cancers, particularly those that occur during childhood, remains unknown, established cancer cause lifestyle (external) factors such as tobacco use and excess body weight and not modified (internal) factors such as inherited genetic mutations, hormones and immune conditions. These factors may act simultaneously or in sequence to initiate and/or promote cancer growth. Ten or more years often pass to expose to external factors and detectable cancers. Not all tumours are cancerous which benign tumours do not extend to other body parts. Cancer also called as a malignant neoplasm or malignant tumour.

International Conference on Cancer and Diagnostics will be the best platform for oncologists, radiologists, pathologists, Immunologists, researchers working in this field to connect and exchange ideas.

Scope and Significance:

Cancer in Japan is becoming a serious health problem. It is the leading cause of mortality in Japan. The annual years of healthy life lost per 100,000 people from cancer in Japan has increased by 57.0% since 1990, an average of 2.5% a year.

International Congress on Cancer and Diagnostics will be the best platform for all the radiologists, oncologists, explore researchers, undergraduates who are working in this field to trade their insight identified with Cancer and oncology. This worldwide meeting is to explore above the frontiers in research in tumour like Lung Cancer, Liver Cancer, Breast Cancer, Kidney Cancer, and Cancer in grown-ups and disease in youngsters. The rate of annual years of healthy life lost because of cancer has changed over time for men and women of specific age groups in Rome. The Importance of International Conference on Cancer and Diagnostics is to redesign, clinically critical gathering of Oncologists and people concerning the confirmation and flow advances in finding and treatment in the field of Cancer Research.

Market Analysis Report:

Worldwide disease drugs advertise represented $78,238.9 million out of 2016. The malignant growth drugs showcase is driven by the developing pervasiveness of different sorts of disease, expanding request of organic and focused on medication treatments, ceaseless patent expiry of key malignancy drugs and the rising effect of Biosimilars. In any case, the mind-boggling expense of medication advancement, the danger of disappointment and the antagonistic impacts of disease tranquilize treatment, especially chemotherapy, blocks the market development. Created countries have executed severe guidelines for the structure and advancement of disease drugs. USFDA and European Union have embraced noteworthy activities to fuel the development of the malignant growth drugs showcase by giving pre-advertise endorsement to potential medications under clinical improvement. Asia-Pacific and LAMEA are promising districts for directing clinical preliminaries due an extensive populace base and the minimal effort of clinical preliminaries when contrasted with North America and Europe. In any case, headway of malignancy sedate research attributable to natural/directed treatments and customized medications hold promising open doors for pharmaceutical, bio-pharmaceutical and biotechnology organizations occupied with creating disease drugs.

Why Japan?

Osaka, Japan’s second largest city is known for its nightlife and foodie, but with the flourishing crowd and the twin tower make this a lively, fun place to visit or live. It is located in the humid subtropical climate zone with 4 different seasons. The month of May witnesses the beautiful winters, which offers wide variety of flowers. The region is well known for lavender which attracts tourists during summer.

Osaka was Japan’s first industrial and commercial hub until 20th century. The groomed shiny skyscrapers are the best scenery from above. Osaka Castle, Dotonbori, Shinsaibashi, Kuromon Ichiba Market, Universal Studio, Hozenji Temple, Shitennoji Temple, Osaka Aquarium Kaiyukan, Umeda Sky Building, Winter Ski & Snowboarding are some of the tourist’s spots while visiting Osaka.

Malignant growth has been the main source of death in Italy with the age-balanced death rate from the two disease libraries being 89.7 per 100 000 in guys, 67.2 per 100 000 in females in Khon Kaen and 133.3 in guys, 121.0 in females in Chiang Mai The assessed age-balanced frequency rates of disease for all locales in Italy were 150.4 per 100 000 for guys and 123.0 for females which are not so noteworthy when contrasted and before information (149.6 for guys and 125.2 for females) .The Rome information were acquired by a cross-sectional overview. Liver malignant growth, particularly cholangiocarcinoma, is first in Khon Kaen, while lung disease prevails in the North and esophageal malignancy is fundamentally high in the South.

Why to Attend?

The International Congress on Cancer and Diagnostics will connect the holes between the intelligent people over the World to illuminate their exploration and discoveries at International Conference on Cancer Science and Diagnostics. Gathering will be helpful to participants to trade their thoughts and system with driving oncologists and clinicians. This Medical Conference unites the top universal researchers and clinicians, examine and new therapeutics. Members can increase direct access to a center crowd of experts and can expand perceivability through marking and systems administration at the meeting. Rome is as inebriating as it is various; a blend of colorful fragrances, intriguing sights and visual joys. It's a city with endless layers which you have to investigate to uncover its concealed mysteries. It is a city blasting to the creases with spectacular sanctuaries, clamoring neighborhood markets, lively nightlife and tremendous shopping buildings, choosing which attractions should make the cut was no simple assignment, working up enthusiastic discussion among our group of Rome specialists.

Target Audience:

Oncologists

Radiologists

Immunologists

Clinical Researchers

Nursing

Malignancy Researchers

Researchers

Youthful Researchers

Undergraduates

Biomarker Associations and Societies

Business Entrepreneurs

Preparing Institutes

Programming creating organizations

Information Management Companies

Pharmaceutical Companies

Diagnostics Companies

Conference Highlights:

Cancer Biomarkers

Cancer Immunology & Immunotherapy

Cancer: Lifestyle and Nutrition

Oncology Nursing and Care

Cancer Screening

Targeted Cancer Therapies

Cancer Diagnosis & Cancer diagnostics

Pharmaceutical Oncology

Oncology Saviors

Cancer Science & Cancer Therapies

Cancer Vaccination

Cancer Prevention

Cancer Bioinformatics

Hormonal Therapy

Cancer Biology

Cancer Pharmacology

Major Cancer Associations across the Globe:

American Association for Cancer Research
Virginia Cancer Institute
American Brain Tumor Association
American Society of Pediatric Hematology/Oncology
Association of Cancer Physicians
American Childhood Cancer Organization
American Society of Clinical Oncology
Australasian Lung Cancer Trials Group
International Cancer Research Partnership (ICRP)
American Association for Cancer Research (AACR)
American Society of Clinical Oncology (ASCO)
International Agency for Research on Cancer (IARC)
Cancer Society of New Zealand
Irish Cancer Society
Australian Cervical Cancer Foundation
Medical Centre Cologne
Cancer Research UK
Australian Prostate Cancer Research
Peter McCollum Cancer Centre
The European Cancer Organization (ECCO)
German Cancer Research Centre

Major Medical Universities:

Worldwide

Harvard University
University of Minnesota
Mayo Medical School
Pittsburgh School of Medicine
Yale University
University of Cambridge
University of Oxford Stanford University
Yale University
Emory University
John Hopkins University
Kings College London
Feinberg School of Medicine
University of Wisconsin
UNC School of Medicine
Karolinska University
The University of Tokyo
National University of Singapore (NUS)
Kyoto University
University of Hong Kong (HKU)
Peking University
Seoul National University (SNU)
National Taiwan University (NTU)
Osaka University
Tsinghua University0
The Chinese University of Hong Kong (CUHK)
Fudan University
The Hong Kong University of Science and Technology (HKUST)
Taipei Medical University
Mahidol University
KAIST - Korea Advanced Institute of Science and Technology
Yonsei University
Shanghai Jiao Tong University
Nanyang Technological University (NTU)
Chulalongkorn University
Tohoku University
Tokyo Medical and Dental University
Kyushu University
Nagoya University
Hokkaido University
Sungkyunkwan University
University of Science and Technology of China
Pohang University of Science and Technology (POSTECH)
Korea University
Universiti Malaya (UM)
Zhejiang University
Keio University
Indian Institute of Science
University of Tsukuba
University of Delhi

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	February 19-20-2020
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

32nd International Conference on Cancer Research and Therapy February 19-20-2020 Osaka, Japan

Recommended Global Oncology & Cancer Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Cancer Research 2020

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues